November 15 2019

Scientus Pharma: solving drug development challenges for cannabinoid-based drugs

Click the link to read the full Health Europa article or read the excerpt below.

Here, we learn how they are leveraging state of the art research to lay the groundwork for a pipeline of cannabis-based products and therapies for market. Health Europa sat down with Har Grover, co-founder, Chairman and CEO of Scientus Pharma. Here, we covered several topics involving drug development challenges, but most intriguing was Scientus Pharma’s approach to drug development and commercialisation in the cannabis sector.

Continue reading here.

Back to news